Oracle Life Sciences Central Designer 7.0.1.0 information disclosure
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in Oracle Life Sciences Central Designer 7.0.1.0. The impacted element is an unknown function. Such manipulation leads to information disclosure. This vulnerability is traded as CVE-2026-21970. The attack may be launched remotely. There is no exploit available. Upgrading the affected component is recommended.
Details
A vulnerability, which was classified as problematic, has been found in Oracle Life Sciences Central Designer 7.0.1.0. Affected by this issue is an unknown code block. The manipulation with an unknown input leads to a information disclosure vulnerability. Using CWE to declare the problem leads to CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. Impacted is confidentiality. CVE summarizes:
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
The advisory is available at oracle.com. This vulnerability is handled as CVE-2026-21970 since 01/05/2026. The exploitation is known to be easy. The attack may be launched remotely. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 01/21/2026). This vulnerability is assigned to T1592 by the MITRE ATT&CK project.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2026-3542). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
01/05/2026 CVE reserved01/20/2026 Advisory disclosed
01/20/2026 VulDB entry created
01/21/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-21970 (🔒)
GCVE (CVE): GCVE-0-2026-21970
GCVE (VulDB): GCVE-100-342074
EUVD: 🔒
Entry
Created: 01/20/2026 23:44Updated: 01/21/2026 07:33
Changes: 01/20/2026 23:44 (62), 01/21/2026 07:33 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.